These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28576032)

  • 41. Carboxymethyl cellulose modified graphene oxide as pH-sensitive drug delivery system.
    Rao Z; Ge H; Liu L; Zhu C; Min L; Liu M; Fan L; Li D
    Int J Biol Macromol; 2018 Feb; 107(Pt A):1184-1192. PubMed ID: 28951302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-assembled monothiol-terminated hyperbranched polyglycerols on a gold surface: a comparative study on the structure, morphology, and protein adsorption characteristics with linear poly(ethylene glycol)s.
    J Yeh PY; Kainthan RK; Zou Y; Chiao M; Kizhakkedathu JN
    Langmuir; 2008 May; 24(9):4907-16. PubMed ID: 18361531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The camouflage of graphene oxide by red blood cell membrane with high dispersibility for cancer chemotherapy.
    Xie M; Deng T; Li J; Shen H
    J Colloid Interface Sci; 2021 Jun; 591():290-299. PubMed ID: 33609896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Succinate Functionalization of Hyperbranched Polyglycerol-Coated Magnetic Nanoparticles as a Draw Solute During Forward Osmosis.
    Yang HM; Choi HM; Jang SC; Han MJ; Seo BK; Moon JK; Lee KW
    J Nanosci Nanotechnol; 2015 Oct; 15(10):8279-84. PubMed ID: 26726503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surface-initiated hyperbranched polyglycerol as an ultralow-fouling coating on glass, silicon, and porous silicon substrates.
    Moore E; Delalat B; Vasani R; McPhee G; Thissen H; Voelcker NH
    ACS Appl Mater Interfaces; 2014 Sep; 6(17):15243-52. PubMed ID: 25137525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy.
    Guo Y; Xu H; Li Y; Wu F; Li Y; Bao Y; Yan X; Huang Z; Xu P
    J Biomater Appl; 2017 Jul; 32(1):54-65. PubMed ID: 28554233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro biocompatibility evaluations of hyperbranched polyglycerol hybrid nanostructure as a candidate for nanomedicine applications.
    Zarrabi A; Shokrgozar MA; Vossoughi M; Farokhi M
    J Mater Sci Mater Med; 2014 Feb; 25(2):499-506. PubMed ID: 24293238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, characterization, and biocompatibility of biodegradable hyperbranched polyglycerols from acid-cleavable ketal group functionalized initiators.
    Shenoi RA; Lai BF; Kizhakkedathu JN
    Biomacromolecules; 2012 Oct; 13(10):3018-30. PubMed ID: 22920950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced biocompatibility and biostability of CdTe quantum dots by facile surface-initiated dendritic polymerization.
    Zhou L; Gao C; Xu W; Wang X; Xu Y
    Biomacromolecules; 2009 Jul; 10(7):1865-74. PubMed ID: 19496613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperbranched Polyglycerol Derivatives as Prospective Copper Nanotransporter Candidates.
    Quadir M; Fehse S; Multhaup G; Haag R
    Molecules; 2018 May; 23(6):. PubMed ID: 29861466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols.
    Mugabe C; Liggins RT; Guan D; Manisali I; Chafeeva I; Brooks DE; Heller M; Jackson JK; Burt HM
    Int J Pharm; 2011 Feb; 404(1-2):238-49. PubMed ID: 21093563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclic RGD-modified chitosan/graphene oxide polymers for drug delivery and cellular imaging.
    Wang C; Chen B; Zou M; Cheng G
    Colloids Surf B Biointerfaces; 2014 Oct; 122():332-340. PubMed ID: 25064484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. One-pot synthesis of doxorubicin-loaded multiresponsive nanogels based on hyperbranched polyglycerol.
    Sousa-Herves A; Wedepohl S; Calderón M
    Chem Commun (Camb); 2015 Mar; 51(25):5264-7. PubMed ID: 25757793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery.
    Song MM; Xu HL; Liang JX; Xiang HH; Liu R; Shen YX
    Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():904-911. PubMed ID: 28532109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
    Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined Chemo-photothermal Antitumor Therapy Using Molybdenum Disulfide Modified with Hyperbranched Polyglycidyl.
    Wang K; Chen Q; Xue W; Li S; Liu Z
    ACS Biomater Sci Eng; 2017 Oct; 3(10):2325-2335. PubMed ID: 33445291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging.
    Arsalani N; Fattahi H; Laurent S; Burtea C; Vander Elst L; Muller RN
    Contrast Media Mol Imaging; 2012; 7(2):185-94. PubMed ID: 22434631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and characterization of Zinc (II)-loaded Zeolite/Graphene oxide nanocomposite as a new drug carrier.
    Khatamian M; Divband B; Farahmand-Zahed F
    Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():251-258. PubMed ID: 27207061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biodegradable polyglycerols with randomly distributed ketal groups as multi-functional drug delivery systems.
    Shenoi RA; Lai BF; Imran ul-haq M; Brooks DE; Kizhakkedathu JN
    Biomaterials; 2013 Aug; 34(25):6068-81. PubMed ID: 23688604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural polymer functionalized graphene oxide for co-delivery of anticancer drugs: In-vitro and in-vivo.
    Deb A; Andrews NG; Raghavan V
    Int J Biol Macromol; 2018 Jul; 113():515-525. PubMed ID: 29496437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.